Literature DB >> 27626896

Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.

S Jasemi1, M Douraghi1,2, H Adibhesami1, H Zeraati3, M Rahbar4, M A Boroumand5, A Aliramezani1, S Ghourchian1, M Mohammadzadeh6.   

Abstract

Comprehensive data on drug-resistant patterns of Acinetobacter baumannii isolates in developing countries is limited. We conducted a multihospital study to assess the rate and trend of drug-resistant phenotypes in Ac. baumannii using standardized definitions and to determine the remaining therapeutic options against resistant phenotypes. The 401 nonduplicate isolates were collected from six hospitals which are geographically distributed across Tehran, Iran over a 3-year period. Following PCR of blaOXA-51-like gene, susceptibility testing was performed against nine antimicrobial agent categories. Three hundred and ninety (97%) isolates were resistant to least two carbapenems; carbapenem-resistant Ac. baumannii. The majority of isolates (366, 91·3%) were extensively drug resistant (XDR) and the rest of the isolates were classified as multidrug resistant (26, 6·8%) and susceptible (9, 2·2%). The rate of XDR-AB slightly decreased from 93·8% in 2011 to 89·8% in 2013. A considerable decrease in resistance to doxycycline, minocycline and tigecycline was demonstrated. The XDR-AB isolates showed susceptibility to gentamicin (10·4%), tobramycin (23%), ampicilin-sulbactam (30·1%), minocycline (32·8%), tigecycline (10·7%), doxycycline (21·6%), colistin (100%) and polymixin B (100%). We demonstrated the rising trend of resistance to all antibiotic categories except tetracyclines and folate pathway inhibitors. We found that the treatment options against XDR-AB are extremely limited and each treatment alternative including even old, but safe, antibiotics might be considered. SIGNIFICANCE AND IMPACT OF THE STUDY: The high frequency of drug-resistant phenotypes including carbapenem-resistant Acinetobacter baumannii, multidrug-resistant, and extensively resistant has been demonstrated in Ac. baumannii isolates tested here. As the antibiotic resistance pattern of isolates varies in different geographical regions, this study can provide comprehensive information about the antibiotic resistance profile of Ac. baumannii isolates in Tehran. In addition, the resistance profiles could be effectively considered by clinicians to manage antibiotic therapy. This work also emphasizes on the prudent use of antibiotics and the monitoring of antibiotic susceptibility trend and rate.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Acinetobacter baumanniizzm321990; antibiotic resistance; carbapenem-resistant Ac. baumannii; colistin; extensively drug-resistant Ac. baumannii; multidrug-resistant; nosocomial pathogen; resistant phenotypes

Mesh:

Substances:

Year:  2016        PMID: 27626896     DOI: 10.1111/lam.12669

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  6 in total

1.  Investigation of Class I, II, and III Integrons Among Acinetobacter Baumannii Isolates from Hospitalized Patients in Isfahan, Iran.

Authors:  Mehrdad Halaji; Aliakbar Rezaei; Mehrdad Zalipoor; Jamshid Faghri
Journal:  Oman Med J       Date:  2018-01

Review 2.  Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea.

Authors:  Young Ah Kim; Yoon Soo Park
Journal:  Korean J Intern Med       Date:  2018-02-27       Impact factor: 2.884

3.  Molecular characterization and clonal dynamics of nosocomial blaOXA-23 producing XDR Acinetobacter baumannii.

Authors:  Sabrina Royer; Paola Amaral de Campos; Bruna Fuga Araújo; Melina Lorraine Ferreira; Iara Rossi Gonçalves; Deivid William da Fonseca Batistão; Rebecca Tavares E Silva Brígido; Louise Teixeira Cerdeira; Luiz Gustavo Machado; Cristiane Silveira de Brito; Paulo Pinto Gontijo-Filho; Rosineide Marques Ribas
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

4.  A Comprehensive Study of the Relationship between the Production of β-Lactamase Enzymes and Iron/Siderophore Uptake Regulatory Genes in Clinical Isolates of Acinetobacter baumannii.

Authors:  Mahyar Porbaran; Hamed Tahmasebi; MohammadReza Arabestani
Journal:  Int J Microbiol       Date:  2021-03-17

5.  Abrupt Increase in Rate of Imipenem Resistance in Acinetobacter baumannii Complex Strains Isolated from General Hospitals in Korea and Correlation With Carbapenem Administration During 2002-2013.

Authors:  Young Ah Kim; Yoon Soo Park; Taemi Youk; Hyukmin Lee; Kyungwon Lee
Journal:  Ann Lab Med       Date:  2018-03       Impact factor: 3.464

6.  Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Lineage 2, Global Clone 1, from Outbreaks in 2012-2013 at a Tehran Burns Hospital.

Authors:  Masoumeh Douraghi; Johanna J Kenyon; Parisa Aris; Mahla Asadian; Sedighe Ghourchian; Mohammad Hamidian
Journal:  mSphere       Date:  2020-04-08       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.